Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of AJU-G721 and G721R in Healthy Adult Males
NCT07643220Phase 1Completed
- Sponsor
- AJU PHARM Co., Ltd.
- Start
- Jun 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in benign prostatic hyperplasia (BPH) (2 arms), sponsored by AJU PHARM Co., Ltd. Primary endpoints: Maximum Observed Plasma Concentration and Area Under the Plasma Concentration-Time Curve From Time Zero to Time t. Started Jun 2026; status: completed.
02
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT07643220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07643220.